Terapias Avanzadas para Tumores Sólidos Pediátricos
Publikationen (14) Publikationen, an denen Forscher/innen teilgenommen haben
2024
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis
Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574
-
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report
Journal of Neurology
-
Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry
STAR Protocols, Vol. 5, Núm. 1
-
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice
Molecular Therapy, Vol. 32, Núm. 3, pp. 722-733
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
-
Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment
Methods in Cell Biology (Academic Press Inc.), pp. 79-97
-
Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study
The Lancet Regional Health - Europe, Vol. 41
-
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
The Lancet Oncology, Vol. 25, Núm. 5, pp. e205-e216
-
Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
Molecular Oncology
-
Radiotherapy protocols for mouse cancer model
Methods in Cell Biology (Academic Press Inc.), pp. 99-113
-
Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation
Scientific Reports, Vol. 14, Núm. 1
-
The immune system: uncharted pathways between senses and the brain
Neural Regeneration Research, Vol. 19, Núm. 6, pp. 1173-1174
-
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
eBioMedicine, Vol. 102